Parkinson's disease
Neurology Blood Tests Primed to Improve Diagnosis, Management of Patients in Alzheimer's and Beyond
Premium
Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic mainstream.
C2N Wins $1.5M Grant From Michael J Fox Foundation to Study Links Between Neurodegenerative Diseases
The firm will use its blood-based tests to explore connections between Alzheimer's disease and neuronal α-synuclein conditions including Parkinson's disease.
Grifols Secures $21M MJFF Grant to Search for Early Parkinson's Biomarkers
Grifols subsidiary Alkahest will lead a pilot study to track proteomic changes in patient plasma samples over a 10-year period.
Sunbird Bio Nabs $14M in Financing
The firm said that it will use the investments to support the development of its blood-based tests to aid the diagnosis and treatment of neurological disorders.
Neurology Dx Firm Amprion Closes $6M of Planned $15M Series B Round
The round, which was led by Formation Venture Engineering, will support commercialization of the company's SAAmplify-ɑSYN biomarker test as well as increased R&D.